Zidovudine (AZT) is widely used in the treatment of human inmunodefici
ency virus (HIV) infection because of its ability to act as a false su
bstrate for the viral reverse transcriptase. AZT in the clinical setti
ng has also been shown to produce significant hematologic and other to
xicity, even though prior reports in the literature indicate that AZT
is not readily incorporated into mammalian nuclear DNA, The human myel
oid leukemia cell line HL-60 was grown in the presence of radiolabeled
AZT or radiolabeled deoxythymidine as an in vitro model to study AZT
toxicity for human myeloid cells, Radioactivity was reversibly incorpo
rated into the mitochondria, suggesting that AZT toxicity may result i
n part from its toxic effects on human mitochondria rather than on hum
an nuclear DNA.